403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Animal Healthcare Market Size Worth USD 159.56 Billion By 2034
| Report Coverage | Details | |
| Market Size in 2024 | USD 67.03 Billion | |
| Market Size in 2025 | USD 73.10 Billion | |
| Market Size in 2026 | USD 79.73 Billion | |
| Market Size by 2034 | USD 159.56 Billion | |
| CAGR from 2025 to 2034 | 9.06% | |
| Base Year | 2024 | |
| Forecast Period | 2025 to 2034 | |
| Segments Covered | Animal Type, Product, Distribution Channel, End Use, Treatments, and Region | |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Set up a meeting at your convenience to get more insights instantly!
Case Study: APAC POC Diagnostics + Tele-Vet Rollout That Shifted Growth Drivers
Compress diagnostic turnaround time (TAT), lift preventive care uptake, and expand pharmacy
Setting
Multi-city veterinary network (85 clinics; 6 Tier-1 labs) serving companion and production animals. Baseline: 48–72h lab TAT; low wellness plan adoption; fragmented pharmacy sales.
Intervention (12 months)
Deploy point-of-care (POC) hematology/biochemistry/immunoassay analyzers to 70 clinics. Integrate cloud LIMS with tele-vet triage and e-Rx to hospital/clinic pharmacies. Launch production-animal health packages: vaccination, deworming, mastitis early-detect, and feed additive adherence tracking. Introduce pet wellness plans bundled with diagnostics (annual CBC/CMP/thyroid, parasitic screens) and remote follow-ups. Train staff on antimicrobial stewardship protocols; gate certain antibiotics behind culture/sensitivity results. Execution
Phased rollout (pilot 10 sites → scale 60 sites → optimize 15 sites). KPI dashboards updated daily (TAT, case mix, Rx capture, re-visit rate, antibiotic DDD/1,000 patient-days).
Outcomes (Month 12 vs Baseline)
- TAT: 48–72h → 15–20 min (POC) for 62% of test volume; reference labs reserved for complex panels. Case conversion: Diagnostic-led consults +28%; wellness plan attachment from 9% → 31%. Revenue mix: Hospital/clinic pharmacy share +540 bps; average Rx capture 58% → 71%. Production-animal KPIs: Milk-yield loss from subclinical mastitis −22%; vaccine adherence +35%. Clinical quality: Empirical antibiotic starts −26%; culture-guided therapy +19%; re-visit within 14 days −14%. Digital utilization: Tele-vet follow-ups account for 24% of post-diagnosis visits; no-show rate −18%. Customer economics: ARPU +17%; churn −9%.
Financial Impact
- Capex (POC analyzers, LIMS, training): USD 2.1M. Payback: 14 months. EBITDA margin uplift: +260 bps network-wide; pharmacy gross margin dollars +23%. Incremental annualized revenue: USD 9.4M; ROI at Month 18: >300%.
Why it Mapped to Market Dynamics
- Fastest APAC growth captured via decentralized diagnostics and tele-care. Hospital/clinic pharmacies reinforced as leading distribution channel. Reference labs remained scale hubs for complex testing while POC unlocked same-visit treatment decisions. Companion-animal humanization monetized through wellness bundles; production-animal programs improved yield and biosecurity.
Replication Playbook
- Start with 10–15 clinics; prioritize sites with >30 daily consults. Bundle 3 core POC panels per species; standardize e-Rx to in-clinic pharmacy. Track four KPIs weekly: POC TAT, wellness attachment, Rx capture, antibiotic stewardship compliance. Reinvest first six months' pharmacy uplift into staff incentives and owner education.
Why North America Dominates the Animal Healthcare Market?
North America dominated the market in 2024. The high percentage of households that own pets and the presence of advanced veterinary infrastructure help the market growth. The strong government support for animal health & welfare and the availability of tele-veterinary services increase demand for animal products & services.
The growing consumption of dairy & meat products and the high prevalence of animal diseases drive the overall growth of the market. The growing trend of pet humanization and advancements in diagnostic and digital technologies are solidifying the regional growth.
What is the U.S. Animal Healthcare Market Size?
According to Precedence Research, the U.S. animal healthcare market size is predicted to rise from USD 18.64 billion in 2025 to approximately USD 41.56 billion by 2034, with an expected CAGR of 9.29% from 2025 to 2034.
Well-established Veterinary Infrastructure Fueling the U.S. Market
The U.S. dominates the regional market due to its highly developed veterinary infrastructure, substantial investment in pet care, and strong presence of major pharmaceutical and biotechnology companies.
The country's high pet ownership rates, growing demand for animal-derived food products Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy – Get the Sample Report@
How the Asia Pacific is Experiencing the Fastest Growth in the Animal Healthcare Market?
Asia Pacific is experiencing the fastest growth in the market during the forecast period. The increasing pet ownership and focus on humanization of pets increases demand for veterinary care & services. The growing demand for animal protein and focus on the management of infectious diseases in animals increase the adoption of animal healthcare.
The growing demand for companion & livestock animals and increasing awareness about animal health support the overall market growth. The expanding livestock and companion animal sector are the fueling this growth.
Large Livestock Population: To Boost Indian Market
India dominates the regional market due to its large livestock population, growing demand for animal proteinThe government's increasing focus on livestock health through initiatives like the National Animal Disease Control Program (NADCP), along with rising awareness among farmers about animal welfare and disease management, has significantly boosted market growth.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at ...Animal Healthcare Market Segmentation Insights:
Animal Type Insights
Why the Production Animal Segment Dominates the Animal Healthcare Market?
The production animal segment dominated the market in 2024. The growing population of animals like swine, poultry, and cattle increases demand for animal healthcare. The high prevalence of zoonotic diseases in production animals and the focus on antimicrobial resistance in animals require animal healthcare services. The high consumption of eggs, protein, & milk, and strong government support for the production of animals, drives the overall growth of the market.
The companion animal segment is experiencing the fastest growth in the market during the forecast period. The rise in ownership of pets and the focus on the development of the human-animal bond increase the adoption of companion animals. The rise in pet insurance
Product Insights
How did the Pharmaceutical Segment hold the Largest Share in the Animal Healthcare Market?
The pharmaceutical segment held the largest revenue share in the market in 2024. The innovations in veterinary medicine and the high prevalence of chronic & zoonotic diseases increase the adoption of pharmaceuticals. The strong focus on high-quality veterinary care and the rise in ownership of pets require pharmaceuticals. The focus on the treatment of farm animals & pet animals' conditions increases adoption of pharmaceuticals, drives the overall market growth.
The veterinary diagnostics segment is the fastest-growing in the market during the forecast period. The growing ownership of companion animals and focus on humanization of pets increases the adoption of veterinary diagnostics. The increasing awareness about early detection of diseases in livestock & companion animals and the spread of infectious diseases in livestock requires veterinary diagnostics, supporting the overall market growth.
Distribution Channel Insights
Why Hospital or Clinic Pharmacy Segment Dominating the Animal Healthcare Market?
The hospital/clinic pharmacy segment dominated the market in 2024. The strong focus on veterinary care and the growing early diagnosis of diseases in animals increases the adoption of hospital/clinic pharmacy. The presence of vaccines & pharmaceuticals in hospitals & clinics helps the market growth. The growing demand for specialized veterinary care and the high volume of animal procedures drive the overall market growth.
The retail pharmacies segment is experiencing the fastest growth in the market during the forecast period. The growing ownership of pets and focus on pet humanization increases demand for retail pharmacies. The increasing awareness about preventive care in animals and the need for OTC products increases demand for retail pharmacies. The rise in veterinary medicine and growth in e-commerce platforms
End Use Insights
Which End-Use Segment Held the Largest Share in the Animal Healthcare Market?
The veterinary reference segment held the largest revenue share in the market in 2024. The growing demand for advanced tests like toxicology, molecular diagnostics
The point-of-care or in-house testing segment is the fastest-growing in the market during the forecast period. The increasing ownership of pets and focus on instant diagnosis of diseases increases the adoption of in-house testing. The high prevalence of chronic & zoonotic diseases and the need for accessible diagnostics require point-of-care. The rise in pet ownership and increasing awareness about pet health support the overall market growth.
Treatments Insights
Why Allergies Segment Dominates the Animal Healthcare Market?
The allergies segment dominated the market in 2024. The growing allergies in animals like cats and dogs increases the adoption of animal healthcare. The high prevalence of allergic skin diseases in companion animals and growth in allergens like mold, pollen, & dust increases adoption of animal healthcare, driving the overall market growth.
The gastrointestinal (GI) diseases segment is experiencing the fastest growth in the market during the forecast period. The high prevalence of GI in dogs and increased consumption of animal protein increase demand for animal healthcare. The increasing prevalence of intestinal disorders in livestock helps the market growth. The rise in issues like obesity, parasitic infections, & inflammatory bowel diseases in pets supports the overall market growth.
You can place an order or ask any questions, please feel free to contact at ... | +1 804 441 9344
Top Companies in the Animal Healthcare Market & Their Offering
- Elanco: expanding its offerings by acquiring other animal health companies, such as Kindred Biosciences and Bayer Animal Health's business, to bolster its portfolio in both companion and food animal markets.
Bayer: is no longer focused on animal health, having exited the business to concentrate on its core life science segments of pharmaceuticals, consumer health, and crop science.
Dechra Pharmaceuticals: has grown its offerings by specializing in underserved veterinary therapeutic areas like endocrinology, dermatology, and critical care, largely through strategic international acquisitions.
Neogen: is expanding its animal safety and genomics offerings through acquisitions, such as 3M's food-safety business, to provide advanced diagnostic and monitoring solutions.
Boehringer Ingelheim: is expanding its offerings through strategic partnerships and R&D focused on first-in-class innovation for animal disease prediction, prevention, and treatment.
Merck & Co, Inc. (Merck Animal Health): expands its offerings through extensive R&D investment and a suite of connected technology solutions for identification, traceability, and health management.
Zoetis: is strengthening its offerings by investing heavily in R&D and expanding its global capability centers to develop innovative digital and AI-driven solutions for animal health.
Nutreco N.V.: expands its product lines, such as Trouw Nutrition (animal feed) and Skretting (aquafeed), by providing nutritional advice and advanced technology to improve sustainable food production.
Virbac: focuses on offering a comprehensive range of veterinary pharmaceuticals and diagnostics by continually investing in R&D and supporting both B2B and B2C channels through global e-commerce expansion.
Vetoquinol S.A.: is expanding its presence by providing a wide range of veterinary drugs and non-medicinal products for companion and production animals, along with new digital applications and services.
Recent Developments:
- In March 2025, Privo Technologies Inc. launched a new subsidiary, BeneVet Oncology, for advancing companion animal health. The subsidiary supports cutting-edge drug delivery systems and revolutionizes the treatment of diseases in pets. (Source: )
In May 2025, Minister N. S. Boseraju launched the cutting-edge veterinary platform, Petologists for pet parents, clinics, & farms. The app includes features like vaccination tracking, farm animal monitoring, digital health records, telemedicine consultations, & medication reminders. (Source: )
In February 2024, Tata Trusts launched India's first animal hospital in Mumbai. The facility is present across 98000 Sq Ft with a capacity of over 200 beds. (Source: )
Segments Covered in the Report
By Animal Type
- Production Animal
- Poultry Swine Cattle Fish Others
- Dogs Cats Horses Others
By Product
- Vaccines
- Live Attenuated Vaccines DNA Vaccines Recombinant Vaccines Inactivated Vaccines Others
- Parasiticides Anti-infective Anti-inflammatory Analgesics Others
- Instruments Consumables
- Critical Care Consumables Anesthesia Equipment Fluid Management Equipment Temperature Management Equipment Rescue & Resuscitation Equipment Research Equipment Patient Monitoring Equipment
- Veterinary Telehealth Veterinary Software Livestock Monitoring
By Distribution Channel
- Retail Pharmacy E-commerce Hospital Pharmacy
By End Use
- Reference Laboratories Point of care testing/ in-house testing Veterinary Hospitals & Clinics Others
By Treatments
- Allergies Arthritis Difficult Dermatology Cases Gastrointestinal Disease Others
By Region
- North America
- U.S. Canada
- Germany UK France Italy Spain Sweden Denmark Norway
- China Japan India South Korea Thailand
- Brazil Mexico Argentina
- South Africa UAE Saudi Arabia Kuwait
Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@Stay Ahead with Precedence Research Subscriptions
Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.
Browse Our Subscription Plans@About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web:Our Trusted Data Partners:
Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Market Stats Insight | Nutraceuticals Func Foods | Onco Quant | Sustainability QuantGet Recent News:
/newsFor the Latest Update Follow Us:
LinkedIn | Medium | Facebook | Twitter✚ Related Topics You May Find Useful:
➡️ Companion Animal Health Market ➡️ Veterinary API Market ➡️ Pet Care Market ➡️ Veterinary Antibiotics Market ➡️ Animal Genetics Market ➡️ Veterinary Point-of-Care Diagnostics Market ➡️ Animal Vaccine Market ➡️ Albendazole Veterinary Market ➡️ Livestock Animal Rehabilitation Services Market ➡️ Veterinary Parasiticides Market ➡️ Veterinary Imaging Market
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment